BGS expands laboratory and logistics spaces

BGS, specialised provider in the area of radiation sterilization and radiation crosslinking, is expanding its halls for logistics and production in Wiehl (NRW). In order to meet the increased material testing requirements for radiation crosslinking, the company is also investing in the extension of a new laboratory.

Author: Lena Prinz

Published: Last updated:

News

1 Min. Reading time
Woman working on glass flasks in laboratory.
Woman working on glass flasks in laboratory.

With the announced extended storage capacities, BGS is responding in particular to the increased need for sterilization services in the sectors of biotechnology, medicine and diagnostics. Overall, BGS is investing a seven-digit amount in the expansion. The additionally planned spaces amount to 1,000 sq m.

“The demand for sterilization capacities is rising steadily. Continuously more orders for crosslinking are being placed at our headquarters in Wiehl. After the move to our new administration quarters in 2020, it is an ideal time to consolidate the freed up space, improve the internal flow of goods in the process, and use the new capacities optimally for the further growth of our company,” explains managing director Dr. Andreas Ostrowicki. “The material testing requirements are also increasing commensurate with the rising number of orders for crosslinking services. With our new spatial possibilities and cutting-edge test equipment, BGS is well prepared to meet the increased requirements.”

Depending on the product and the respective area of application, BGS carries out the relevant test procedures such as measuring the degree of crosslinking as well as rheological measurements, amongst others, for customers from the automotive industry, machine construction and the cable and pipe industry. The completion of all construction measures is planned for 2024.

New laboratory supports R&D activities of the medium-sized company

The new equipment and possibilities in the laboratory also benefit the research and development department at BGS. “The focus of our R & D activities at present is the development of new, crosslinkable materials, alternative crosslinking aids and solutions for the sustainability of radiation-crosslinked parts and components,” declares managing director Ostrowicki. “As part of the German innovation network ZIM (Central Innovation Programme) MED-IG-4.0, we are additionally working to further accelerate the progress of the Internet of Things in the medical sector: For example, together with 22 other medium-sized enterprises, we analyse the need for intelligent products and systems from thermoplastic materials, develop new products and improve existing solutions.”

This year, for the first time, Stifterverband für die Deutsche Wissenschaft e.V. (Donors’ Association for the Promotion of Sciences and Humanities in Germany) awarded BGS the seal “Innovative through Research” for its achievements in the area of research and development.

More News

  • BGS website on a tablet

    Published on 05.09.2024News

    Website relaunch: BGS’s new online presence

    With a modern design, mobile-optimized and expanded content: BGS has completely relaunched it´s website to make it more user-friendly for customers and interested parties. The new website has been online since September 2, 2024.

  • Neues Labor von BGS mit einer Person
    Crosslinking orders from customers in the automotive, mechanical engineering, infrastructure and electrical industries, among others, are tested in the new laboratory. Copyright photo: Lina Sommer / BGS

    Published on 03.09.2024News

    New laboratory and expanded logistics space put into operation at BGS

    BGS has built new laboratory facilities at its site in Wiehl (NRW) and expanded its logistics and production halls by an additional 1,000 m2. BGS is thus responding to the increased demand for sterilization services in the biotechnology, medical and…

This site is registered on wpml.org as a development site. Switch to a production site key to remove this banner.